Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Ignacio Fernández Blanco"'
Autor:
J L Pérez-Calle, David Busquets, Marta Calvo, Fernando Muñoz, Cristobal De la Coba, Ángel Ponferrada, Ignacio Fernández-Blanco, David Olivares, Cristina Alba, María Chaparro, Xavier Calvet, Carlos Taxonera, Manuel Barreiro-de Acosta, R. Pajares, Eva Iglesias, Antonio Rodríguez, Fernando Bermejo, Pilar López-Serrano, Javier P. Gisbert
Publikováno v:
Digestive Diseases and Sciences. 62:481-490
The impact of prior anti-TNF use on “real-life” outcomes of adalimumab therapy in ulcerative colitis (UC) is not well known. To compare the influence of prior anti-TNF use on the outcomes of adalimumab maintenance treatment in UC patients. We als
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f9a27fa9a0bf0612f068dcfa3adc7c2
https://doi.org/10.1007/s10620-016-4398-5
https://doi.org/10.1007/s10620-016-4398-5
Autor:
Ignacio Fernández-Blanco, David Olivares, María Gómez-García, Rocío Plaza, Juan Luis Mendoza, Carlos Taxonera, Ignacio Marín-Jiménez, Cristina Alba, Leticia Pérez-Carazo, Fernando Bermejo, Pilar López-Serrano, María Chaparro, Antonio López-Sanromán, Javier Martinez-Gonzalez, M. Barreiro-de-Acosta, Olga Merino, Cristina Saro, Javier P. Gisbert, Guillermo Bastida, Valle García-Sánchez, Eva Iglesias
Publikováno v:
Journal of Crohn's & colitis
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Background and aims: The aims of this study were to evaluate the frequency of entero-urinary fistulas in a cohort of Crohn’s disease (CD) patients and to analyse the outcomes of medical and surgical therapy. Methods: This multicentre retrospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3918c55f8ab47a4d00025f2ebe774f0e
https://doi.org/10.1093/ecco-jcc/jjw016
https://doi.org/10.1093/ecco-jcc/jjw016
Autor:
Carlos Taxonera, María Isabel Vera, J Ignacio Fernández-Blanco, Guillermo Fernandez-Diaz, David Olivares, Carlos Cara
Publikováno v:
Digestive diseases and sciences. 63(3)
Histological remission represents a target distinct from endoscopic healing in ulcerative colitis (UC) and seems a better predictor of clinical outcomes. The aim of this study was to assess the ability of adalimumab to achieve histological remission
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44f7d6a928cb059259414c9e354344ff
https://pubmed.ncbi.nlm.nih.gov/29372480
https://pubmed.ncbi.nlm.nih.gov/29372480
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J.L. Mendoza, Guillermo Bastida, Cristina Saro, S. Garcia-Morán, Jesús Estellés, Elena Gento, Isabel Vera, Ignacio Fernández-Blanco, M. Barreiro-de Acosta, María Chaparro Sánchez, Pilar Martínez-Montiel, Olga Merino, Ignacio Marín-Jiménez, Valle García-Sánchez, Javier P. Gisbert, Carlos Taxonera
Publikováno v:
Alimentary Pharmacology & Therapeutics. 33:340-348
Aliment Pharmacol Ther 2011; 33: 340–348 Summary Background The long-term efficacy of adalimumab in patients with ulcerative colitis is not well known. Aim To evaluate the short- and long-term outcomes of adalimumab in ulcerative colitis patients p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aeea701ddf79f2cdd89c47697dedeef9
https://doi.org/10.1111/j.1365-2036.2010.04531.x
https://doi.org/10.1111/j.1365-2036.2010.04531.x
Autor:
Carlos Taxonera, Cristina Saro, Valle García-Sánchez, R. Pajares, Juan Luis Mendoza, M. P. Martínez-Montiel, Marta Calvo, Ángel Ponferrada, Cristina Alba, Ignacio Marín-Jiménez, María Chaparro, Celia de Gracia, Javier P. Gisbert, María Dolores Martín-Arranz, Manuel Barreiro-de Acosta, Guillermo Bastida, Fernando Bermejo, Ignacio Fernández-Blanco, David Olivares
Publikováno v:
Digestive diseases and sciences. 60(10)
The outcomes of infliximab dose escalation in ulcerative colitis (UC) have not been well evaluated. To assess the short- and long-term outcomes of infliximab dose escalation in a cohort of patients with UC. This was a multicenter, retrospective, coho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::234d19033d16ad777e679ae6016e3867
https://pubmed.ncbi.nlm.nih.gov/26044830
https://pubmed.ncbi.nlm.nih.gov/26044830
Autor:
J.P. Gisbert, Carlos Taxonera, Francisco Javier Bermejo, R. Plaza, M. Barreiro-de Acosta, Pilar López-Serrano, Ignacio Marín-Jiménez, María José Casanova, Valle García-Sánchez, María Gómez-García, E. Iglesias, Alicia Algaba, J.L. Mendoza, Ignacio Fernández-Blanco, Guillermo Bastida, David Olivares, Cristina Saro
Publikováno v:
Journal of Crohn's and Colitis. 8:S230-S231
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1887f25deb17dcbc32135a8129e14938
https://doi.org/10.1016/s1873-9946(14)60516-x
https://doi.org/10.1016/s1873-9946(14)60516-x
Autor:
Xavier Calvet, Antonio Rodríguez, Javier P. Gisbert, Cristina Alba, María Chaparro, Cristobal De la Coba, Ignacio Fernández-Blanco, David Olivares, Carlos Taxonera, Fernando Bermejo, Manuel Barreiro-de Acosta, José Lázaro Pérez-Calle, David Busquets, Eva Iglesias Flores, Pilar López-Serrano, A. Díaz, R. Pajares, Fernando Muñoz, Marta Calvo
Publikováno v:
Gastroenterology. 148:S-789
Adalimumab Dose Escalation Is Effective for Managing Loss of Response in Ulcerative Colitis Carlos Taxonera, Eva Iglesias Flores, Fernando Munoz, Marta Calvo, Manuel Barreiro-de Acosta, David Busquets, Xavier Calvet, Antonio Rodriguez, R. Pajares, Ja
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4de616f0f1f1b3467ba086d1cdf949d
https://doi.org/10.1016/s0016-5085(15)32695-0
https://doi.org/10.1016/s0016-5085(15)32695-0
Publikováno v:
Gastroenterology. 148:S-791
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b6c06600813849f0f5625bde2de32ea
https://doi.org/10.1016/s0016-5085(15)32701-3
https://doi.org/10.1016/s0016-5085(15)32701-3
Autor:
J.L. Pérez Calle, J.L. Mendoza, C. Froilan, V. Gonzalez-Lara, J. A. Solís Herruzo, M. Luna-Chadid, José Maté-Jiménez, F.J. Sánchez, Andrea Bermejo, Ignacio Fernández-Blanco, Javier P. Gisbert, M.I. Vera, J. Garcia-Paredes, A. López San Román, B. Casis, L. Abreu
Publikováno v:
Revista Española de Enfermedades Digestivas v.96 n.6 2004
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Europe PubMed Central
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Europe PubMed Central
Objective To evaluate the efficacy and toxicity of infliximab for the treatment of fistulizing Crohn's disease. Methods Consecutive patients with fistulizing Crohn's disease receiving infliximab were prospectively enrolled. Partial response was defin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e9b5f2591d3ca790e708885b5457369
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082004000600003
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082004000600003
